X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ACTAVIS (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ACTAVIS
Dec-18
ALEMBIC LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs7213,493-   
Low Rs349,051-   
Sales per share (Unadj.) Rs4.73,309.8-  
Earnings per share (Unadj.) Rs6.1-1,066.1-  
Cash flow per share (Unadj.) Rs6.2348.8-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.713,651.2-  
Shares outstanding (eoy) m267.03332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.4 330.8%   
Avg P/E ratio x8.7-10.6 -82.0%  
P/CF ratio (eoy) x8.532.3 26.2%  
Price / Book Value ratio x1.30.8 157.7%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1393,749,019 0.4%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM65,137.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-20,980.9-  
INCOME DATA
Net Sales Rs m1,2551,100,828 0.1%  
Other income Rs m37021,051 1.8%   
Total revenues Rs m1,6251,121,879 0.1%   
Gross profit Rs m11128,847 0.4%  
Depreciation Rs m38470,580 0.0%   
Interest Rs m263,524 0.0%   
Profit before tax Rs m442-484,205 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0123,492 0.0%   
Tax Rs m24-6,136 -0.4%   
Profit after tax Rs m1,630-354,577 -0.5%  
Gross profit margin %8.92.6 337.8%  
Effective tax rate %5.41.3 427.8%   
Net profit margin %129.8-32.2 -403.1%  
BALANCE SHEET DATA
Current assets Rs m1,867451,502 0.4%   
Current liabilities Rs m591399,413 0.1%   
Net working cap to sales %101.64.7 2,148.2%  
Current ratio x3.21.1 279.4%  
Inventory Days Days9420 481.3%  
Debtors Days Days7466 110.9%  
Net fixed assets Rs m1,791124,608 1.4%   
Share capital Rs m5340-   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8584,540,399 0.2%   
Long term debt Rs m411,598,839 0.0%   
Total assets Rs m11,5917,097,677 0.2%  
Interest coverage x260.9-6.6 -3,939.4%   
Debt to equity ratio x00.4 1.1%  
Sales to assets ratio x0.10.2 69.8%   
Return on assets %14.1-4.1 -343.3%  
Return on equity %15.0-7.8 -192.2%  
Return on capital %15.2-4.8 -313.8%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236393,284 0.1%  
From Investments Rs m-224216,058 -0.1%  
From Financial Activity Rs m-27-674,993 0.0%  
Net Cashflow Rs m-15-65,323 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.73 Rs / USD

Compare ALEMBIC LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: BIOCON   WOCKHARDT  SHASUN PHARMA  DR. DATSONS LABS  ELDER PHARMA  



Today's Market

Sensex Tanks 491 Points, India's Rising Trade Deficit, and Top Stocks in Action(Pre-Open)

After opening the day marginally lower, share markets in India witnessed negative trading activity throughout Monday and ended deep in the red.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 17, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS